# ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

Study · id `cardio:ct-nct05988411` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05988411](<https://clinicaltrials.gov/study/NCT05988411>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05988411

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 143 participants.

## Technical summary

Registry record NCT05988411. Randomized; single masking; primary purpose treatment. Start 2023-12-07 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 143 participants (enrolled count; ClinicalTrials.gov record NCT05988411, source copy `cardio:ctgov-nct05988411-2026-07-30`, retrieved 2026-10-26)
- Started: 2023-12-07 (actual) (ClinicalTrials.gov record NCT05988411, source copy `cardio:ctgov-nct05988411-2026-07-30`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT05988411, source copy `cardio:ctgov-nct05988411-2026-07-30`, retrieved 2026-10-26)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT05988411, source copy `cardio:ctgov-nct05988411-2026-07-30`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05988411, source copy `cardio:ctgov-nct05988411-2026-07-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05988411-2026-07-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
- Condition: Paroxysmal Atrial Fibrillation
- Condition: Persistent Atrial Fibrillation
- Intervention (Device): Renal Denervation
- Intervention (Device): Catheter Ablation
- Lead sponsor: Vivek Reddy
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Vivek Reddy (`cardio:org-vivek-reddy`)

## Provenance

Content hash: e3d4a31960bd77a6633e47c165f349abae90425408a746acf8dab05a09d307dc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
